NF-KAPPA-B AND TRANSCRIPTIONAL CONTROL OF RENAL EPITHELIAL-INDUCIBLE NITRIC-OXIDE SYNTHASE

被引:48
作者
AMOAHAPRAKU, B
CHANDLER, LJ
HARRISON, JK
TANG, SS
INGELFINGER, JR
GUZMAN, NJ
机构
[1] UNIV FLORIDA,COLL MED,DEPT PHARMACOL,GAINESVILLE,FL 32610
[2] UNIV FLORIDA,COLL MED,DIV NEPHROL HYPERTENS & TRANSPLANTAT,GAINESVILLE,FL 32610
[3] MASSACHUSETTS GEN HOSP,DIV PEDIAT NEPHROL,BOSTON,MA
[4] HARVARD UNIV,SCH MED,BOSTON,MA
关键词
D O I
10.1038/ki.1995.337
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Expression of the inducible isoform of nitric oxide synthase (iNOS) is subject to strict tissue specific transcriptional control. Recently, the NF-kappa B/Rel family of transcription factors, and particularly c-rel, was shown to mediate bacterial lipopolysaccharide (LPS) induction of iNOS in macrophages. Since LPS is only a weak inducer of iNOS in most nonimmune cells, we investigated the role of NF-kappa B in the regulation of iNOS expression in mouse renal epithelial cells. We report that LPS activates NF-kappa B in renal epithelium, but that this is not sufficient for induction of iNOS activity. The NF-kappa B complexes activated by LPS in renal epithelium differ from those in macrophages in that they lack c-rel, which may explain the absence of iNOS induction in renal epithelium. Conversely, LPS and interferon-gamma (IFN) synergize to induce renal epithelial iNOS. Functional iNOS promoter analysis indicate that this synergistic induction requires NF-kappa B. We conclude that NF-kappa B is necessary but not sufficient for the induction of renal epithelial iNOS expression, and that in contrast to macrophages, c-rel does not appear to play a major role in the regulation of renal epithelial iNOS.
引用
收藏
页码:674 / 682
页数:9
相关论文
共 33 条
[1]  
Amoah-Apraku Bismark, 1993, Journal of the American Society of Nephrology, V4, P544
[2]  
BOGDAN C, 1993, J IMMUNOL, V151, P301
[3]  
CHANDLER LJ, 1994, ALCOHOL GLIAL CELLS, V27, P195
[4]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[5]  
COONEY AJ, 1993, TRANSCRIPTION FACTOR, P49
[6]  
DING AH, 1988, J IMMUNOL, V141, P2407
[7]   THE CANDIDATE ONCOPROTEIN BCL-3 IS AN ANTAGONIST OF P50/NF-KAPPA-B-MEDIATED INHIBITION [J].
FRANZOSO, G ;
BOURS, V ;
PARK, S ;
TOMITAYAMAGUCHI, M ;
KELLY, K ;
SIEBENLIST, U .
NATURE, 1992, 359 (6393) :339-342
[8]   CHARACTERIZATION OF A RENAL TUBULAR EPITHELIAL-CELL LINE WHICH SECRETES THE AUTOLOGOUS TARGET ANTIGEN OF AUTOIMMUNE EXPERIMENTAL INTERSTITIAL NEPHRITIS [J].
HAVERTY, TP ;
KELLY, CJ ;
HINES, WH ;
AMENTA, PS ;
WATANABE, M ;
HARPER, RA ;
KEFALIDES, NA ;
NEILSON, EG .
JOURNAL OF CELL BIOLOGY, 1988, 107 (04) :1359-1368
[9]  
HIRAI H, 1992, ONCOGENE, V7, P1737
[10]   NITRIC-OXIDE - A NEW ENDOGENOUS IMMUNOMODULATOR [J].
LANGREHR, JM ;
HOFFMAN, RA ;
LANCASTER, JR ;
SIMMONS, RL .
TRANSPLANTATION, 1993, 55 (06) :1205-1212